Yago Nieto

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant

BMC Cancer(2023)10.1186/s12885-023-11712-6

Top 100%

0DataRank

Top 100%0 citations

Roland L. Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari, Chitra Hosing +12 more

Papers

Driven by 29 papers — median percentile 0. Top paper: “Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors”.

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

New England Journal of Medicine(2020)10.1056/nejmoa1910607

N/A

5.4DataRank · unranked

2164 citations

David Marín, Pinaki P. Banerjee, Homer A. Macapinlac, Philip A. Thompson, Rafet Başar +22 more

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

Nature Medicine(2024)10.1038/s41591-023-02785-8

N/A

4.0DataRank · unranked

468 citations

Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou +31 more

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Journal of Clinical Oncology(2021)10.1200/jco.20.02608

N/A

2.1DataRank · unranked

66 citations

Ruitao Lin, David Marín, Hind Rafei, Mustafa Bdiwi, Peter F. Thall +38 more

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood Advances(2020)10.1182/bloodadvances.2019000784

N/A

2.0DataRank · unranked

65 citations

Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman +21 more

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

The Lancet Haematology(2022)10.1016/s2352-3026(22)00318-0

N/A

1.4DataRank · unranked

41 citations

Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei +20 more

Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.010

N/A

0.618DataRank · unranked

17 citations

Robert Redd, Erin Jeter, Jeff L. Wong, Kristin M McHugh, Carol Reynolds +21 more

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Blood(2023)10.1182/blood.2023020244

N/A

0.598DataRank · unranked

15 citations

Parastoo B. Dahi, Robert Redd, Mikaela M. McDonough, Yi‐Bin Chen, Zachariah DeFilipp +15 more

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities

Blood Advances(2023)10.1182/bloodadvances.2023010850

N/A

0.462DataRank · unranked

12 citations

Oren Pasvolsky, Roland L. Bassett, Rohtesh S. Mehta, Amanda Olson, Julianne Chen +21 more

A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation

Bone Marrow Transplantation(2022)10.1038/s41409-022-01705-7

N/A

0.360DataRank · unranked

10 citations

Peter F. Thall, Junsheng Ma, Benigno C. Valdez, Roland L. Bassett, Julianne Chen +20 more

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.023

N/A

0DataRank · unranked

5 citations

Leonard C. Alsfeld, Denái R. Milton, Ruby Delgado, Uday Popat, Yago Nieto +21 more

Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.06.015

N/A

0DataRank · unranked

9 citations

Uri Greenbaum, Oren Pasvolsky, Denái R. Milton, Rashmi Kanagal‐Shamanna, Jeremy Ramdial +15 more

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

Blood Advances(2023)10.1182/bloodadvances.2022009138

N/A

0DataRank · unranked

36 citations

Mithun Vinod Shah, Anita D’Souza, Noel Estrada‐Merly, Lohith Gowda, Gemlyn George +37 more

Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells

Frontiers in Oncology(2023)10.3389/fonc.2023.1287444

N/A

0DataRank · unranked

8 citations

Bin Yuan, David Murray, Jeremy Ramdial, Yago Nieto, Uday Popat +3 more

Data from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

(2023)10.1158/1078-0432.c.6530711.v1

N/A

0DataRank · unranked

1 citations

Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak +38 more

Patient Characteristics and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Blood(2023)10.1182/blood-2023-181031

N/A

0DataRank · unranked

1 citations

Hina Khan, Denái R. Milton, Oren Pasvolsky, Mark R. Tanner, Uday Popat +18 more

Characteristics and Outcomes of Children, Adolescents and Young Adults with Relapsed/Refractory Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant

Research Square(2023)10.21203/rs.3.rs-2531406/v1

N/A

0DataRank · unranked

0 citations

Oren Pasvolsky, Roland L. Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari +12 more

Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant

BMC Cancer(2023)10.1186/s12885-023-11712-6

Top 100%

0DataRank

Top 100%0 citations

Roland L. Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari, Chitra Hosing +12 more

Safety and efficacy of a new high‐dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high‐risk myeloma: Matched‐pair comparisons with concurrent control cohorts

American Journal of Hematology(2023)10.1002/ajh.27168

N/A

0DataRank · unranked

0 citations

Zixi Yang, Benigno C. Valdez, Suprateek Kundu, Qaiser Bashir, Jeremy Ramdial +3 more

Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.001

N/A

0DataRank · unranked

8 citations

Curtis Marcoux, Jianliang Dai, Denái R. Milton, Mark R. Tanner, Naureen Syed +18 more

ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells

Oncotarget(2024)10.18632/oncotarget.28563

N/A

0DataRank · unranked

6 citations

Bin Yuan, David Murray, Jeremy Ramdial, Uday Popat, Yago Nieto +2 more

High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1917

N/A

0DataRank · unranked

2 citations

John F. Ward, Wayne L. Hofstetter, David C. Rice, José A. Karam, Louis L. Pisters +24 more

Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells

Experimental Hematology(2020)10.1016/j.exphem.2020.01.003

N/A

0DataRank · unranked

14 citations

Yang Li, David Murray, Yan Liu, Yago Nieto, Qaiser Bashir +3 more

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0164

N/A

0DataRank · unranked

153 citations

Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak +38 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6

N/A

0DataRank · unranked

83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia(2021)10.1038/s41375-021-01233-1

N/A

0DataRank · unranked

1 citations

Sagar S. Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Dávila +42 more

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: Implications for their use in combination with PARP inhibitors and chemotherapeutic drugs

Oncotarget(2022)10.18632/oncotarget.28278

N/A

0DataRank · unranked

20 citations

Yago Nieto, Bin Yuan, David Murray, Börje S. Andersson, Benigno C. Valdez

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells

Oncotarget(2022)10.18632/oncotarget.28193

N/A

0DataRank · unranked

15 citations

David Murray, Bin Yuan, Yago Nieto, Uday Popat, Börje S. Andersson +1 more

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica(2022)10.3324/haematol.2022.281954

N/A

0DataRank · unranked

15 citations

Sushanth Gouni, Jason R. Westin, Lei Feng, Haleigh Mistry, Raphaël Steiner +16 more

Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2042689

N/A

0DataRank · unranked

8 citations

Bin Yuan, David Murray, Yago Nieto, Uday Popat, Börje S. Andersson +1 more

Yago Nieto

Indexed papers

Top data-sharing exemplar

Papers